Minerva Fonseca-Arce

Juan Badiano No. 1, C.P. 14080
Tlalpan, DIF 14080, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Vaccination with a Trypanosoma cruzi Protein Extract Plus BCG∆BCG1419c Promotes a Balanced Th1/Th2 Immune Profile That Improves Control of Acute Chagas Disease in BALB/c Mice.

Vaccination with a Trypanosoma cruzi Protein Extract Plus BCG∆BCG1419c Promotes a Balanced Th1/Th2 Immune Profile That Improves Control of Acute Chagas Disease in BALB/c Mice.

Journal: Microorganisms

Published: September 10, 2025

Mycobacterium bovis BCG as immunostimulating agent prevents the severe form of chronic experimental Chagas disease.

Mycobacterium bovis BCG as immunostimulating agent prevents the severe form of chronic experimental Chagas disease.

Journal: Frontiers in immunology

Published: January 31, 2024

Nitazoxanide: A Drug Repositioning Compound with Potential Use in Chagas Disease in a Murine Model.

Nitazoxanide: A Drug Repositioning Compound with Potential Use in Chagas Disease in a Murine Model.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: May 11, 2023

Effectiveness of Nitazoxanide and Electrolyzed Oxiding Water in Treating Chagas Disease in a Canine Model.

Effectiveness of Nitazoxanide and Electrolyzed Oxiding Water in Treating Chagas Disease in a Canine Model.

Journal: Pharmaceutics

Published: March 31, 2023

The Low Variability of Tc24 in Trypanosoma cruzi TcI as an Advantage for Chagas Disease Prophylaxis and Diagnosis in Mexico.

The Low Variability of Tc24 in Trypanosoma cruzi TcI as an Advantage for Chagas Disease Prophylaxis and Diagnosis in Mexico.

Journal: Pathogens (Basel, Switzerland)

Published: December 01, 2022

Chagas Heart Disease: Beyond a Single Complication, from Asymptomatic Disease to Heart Failure.

Chagas Heart Disease: Beyond a Single Complication, from Asymptomatic Disease to Heart Failure.

Journal: Journal of clinical medicine

Published: September 21, 2022

Consensus Enolase of Trypanosoma Cruzi: Evaluation of Their Immunogenic Properties Using a Bioinformatics Approach.

Consensus Enolase of Trypanosoma Cruzi: Evaluation of Their Immunogenic Properties Using a Bioinformatics Approach.

Journal: Life (Basel, Switzerland)

Published: April 14, 2022

Risk of COVID-19 in Chagas Disease Patients: What Happen with Cardiac Affectations?

Risk of COVID-19 in Chagas Disease Patients: What Happen with Cardiac Affectations?

Journal: Biology

Published: April 07, 2021

Electrolyzed Oxidizing Water Modulates the Immune Response in BALB/c Mice Experimentally Infected with Trypanosoma cruzi.

Electrolyzed Oxidizing Water Modulates the Immune Response in BALB/c Mice Experimentally Infected with Trypanosoma cruzi.

Journal: Pathogens (Basel, Switzerland)

Published: September 15, 2020

Echocardiographic Findings in Canine Model of Chagas Disease Immunized with DNA Trypanosoma cruzi Genes.

Echocardiographic Findings in Canine Model of Chagas Disease Immunized with DNA Trypanosoma cruzi Genes.

Journal: Animals : an open access journal from MDPI

Published: March 13, 2020

DNA Vaccine Treatment in Dogs Experimentally Infected with Trypanosoma cruzi.

DNA Vaccine Treatment in Dogs Experimentally Infected with Trypanosoma cruzi.

Journal: Journal of immunology research

Published: December 31, 2019

Recombinant Enolase of Trypanosoma cruzi as a Novel Vaccine Candidate against Chagas Disease in a Mouse Model of Acute Infection.

Recombinant Enolase of Trypanosoma cruzi as a Novel Vaccine Candidate against Chagas Disease in a Mouse Model of Acute Infection.

Journal: Journal of immunology research

Published: February 07, 2018

Showing 1-12 of 23

Last Updated: 09/26/2026